Mexico Pharmaceuticals and Healthcare Report Q3 2012Business Monitor International
May 22, 2012
102 Pages - SKU: BMI3907328
More Prescription Drugs reports by Business Monitor International
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low ...
Pakistan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Increased longevity in developed markets translates into an increased demand for aged carehealthcare services and medicines. However, in emerging markets such as Pakistan, ...
Japan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Japan remains the most attractive market in the Asia Pacific, due to the ageing and affluentpopulation and strong regulatory conditions. In particular, we ...
Croatia Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor InternationalSee all reports like this >>
Executive SummaryBMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to ...
More Mexico Prescription Drugs reports
Mexico Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: The improving performance of Mexico's regulatory system presents more opportunities formultinational pharmaceutical companies seeking to enter the Mexican pharmaceutical market. On the backof ...
Mexico Pharmaceuticals and Healthcare Report Q1 2013 by Business Monitor International
BMI View: The improving regulatory environment and the increasing foreign direct investment makeMexico’s pharmaceutical market more attractive to multinational drugmakers. We project an increase ingovernment ...
Healthcare Landscape, Outlook, and Growth Opportunities in Mexico 2011-2015 by Frost & Sullivan
The purpose of this study is to analyze the Mexican healthcare system, comprising the following segments: pharmaceuticals and biotechnology, medical devices, healthcare IT, medical imaging, ...
Mexico: Market Access Tracker by Decision ResourcesSee all reports like this >>
In recent decades, the Mexican government has worked hard to develop its national healthcare system. The country now has a solid basic healthcare ...
More Mexico reports
D&B Country Report: Mexico by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Spirits – Mexico – a snapshot (2011) by Mintel - Snapshots
Spirits in Mexico by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers all ...
D&B Country RiskLine Report: Mexico by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLineSee all reports like this >>
Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering the Chemicals ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Hospitals & Clinics
- Country Overviews
- Life Sciences
- Country Overviews
- Manufacturing, Packaging & Detailing
- Prescription Drugs
Prescription Drugs Reports